Startups

Prelude Therapeutics just raised a $50M Series C

The Delaware cancer therapy biotech company continues to grow with VC funding.

Life sciences. (Photo by Pexels user Martin Lopez used under a Creative Commons license)

In 2019, Prelude Therapeutics, the Wilmington-based biopharmaceutical oncology company, landed $60 million in Series B funding.

Now, the company has raised a $50 million Series C to continue its growth, its leadership announced on Monday. Investors included OrbiMed Advisors and Fidelity Management & Research Company.

“We are pleased to have the support of this sophisticated group of investors who share our vision of bringing effective new therapies to cancer patients in areas of high unmet need,” said Kris Vaddi, Ph.D., founder and CEO of Prelude Therapeutics, in a statement. “With proceeds from this financing, we believe we are well positioned to continue to execute on building and advancing our pipeline of therapies designed to target key drivers of cancer cell growth, survival and resistance to existing treatments.”

Prelude was founded in 2016 and was once part of the Delaware Innovation Space accelerator. Right now, the biotech company’s therapeutics are being evaluated in clinical trials related to bone marrow-related malignancies and solid tumors including glioblastoma multiforme, which is a malignant tumor affecting the brain or spine.

Prelude also announced two new board members alongside the funding news: Mardi C. Dier, who was most recently EVP, CFO and chief business officer for Portola Pharmaceuticals, Inc., and Dr. Victor Sandor, who was most recently chief medical officer at Array BioPharma, Inc.

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

A new model for thinking about how to grow regional economies: the Innovation Ecosystem Stack

Delaware’s next governor will be an entrepreneur. Here’s why Matt Meyer thinks it matters. 

20 tech community events in October you won’t want to miss

This Week in Jobs: Start Spooky Season with these 27 scary good career opportunities

Technically Media